Trending Updates

The Medicines and Healthcare products Regulatory Agency (MHRA), on behalf of the International Council for Harmonisation

The UK MHRA has opened a public consultation on the draft ICH Q3E guideline, which outlines a harmonised, risk-based fra

The European Chemicals Agency (ECHA) has issued a new recommendation to include four additional substances in the REACH

HSA Singapore warned consumers not to use the product after laboratory testing detected potent undeclared medicinal subs

The FDA Drug Competition Action Plan is a strategic initiative developed by the U.S. Food and Drug Administration to enh

EFSA issued a scientific opinion deriving a health-based guidance value for Δ8-THC and assessing its presence in food an

The TGA published discussions from the Medical Device Reforms Consumer Working Group highlighting expectations for stron

ECHA has recommended adding four SVHCs to Annex XIV of REACH, meaning future uses will require authorisation. The substa